Chen-Wang Chang

Chen-Wang Chang

Auto-generated profile, based on publicly available information

Chen-Wang Chang

Division of Gastroenterology, Department of Internal Medicine Mackay Memorial Hospital Taipei Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2024 in Intestinal Research
Verified
Journal Article
Open access
PDF file
HYHsu-Heng Yen
Hsu-Heng Yen
JWJia-Feng Wu
Jia-Feng Wu
HWHorng-Yuan Wang
Horng-Yuan Wang
TCTing-An Chang
Ting-An Chang
CCChung-Hsin Chang
Chung-Hsin Chang
PTPO-NIEN TSAO
PO-NIEN TSAO
Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in Western countries, its impact remains considerable, demanding updated guidelines for addressing local healthcare challenges and patient needs. The revised guidelines employ international standards and recent research, emphasizing practical implementation within the Taiwanese healthcare system. Since the inception of the guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease has acknowledged the need for ongoing revisions to incorporate emerging therapeutic options and evolving disease management practices. This updated guideline aims to align UC management with local contexts, ensuring comprehensive and context-specific recommendations, thereby raising the standard of care for UC patients in Taiwan. By adapting and optimizing international protocols for local relevance, these efforts seek to enhance health outcomes for patients with UC.

10 September 2016 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MCMing-Jen Chen
Ming-Jen Chen
HWHorng-Yang Wang
Horng-Yang Wang
CCChen-Wang Chang
Chen-Wang Chang
CLChing-Chung Lin
Ching-Chung Lin
CCChih-Jen Chen
Chih-Jen Chen
SSShou-Chuan Shih
Shou-Chuan Shih
We developed a novel artificial simulator for endoscopic submucosal dissection (ESD) as a bridge between instructional videos and animal tissue training and aimed to evaluate the feasibility of using an artificial tissue model in ESD training. Eight gastroenterology fellows from one medical center were enrolled in this ESD training program. Before and after the simulator training, attendees indicated on a 5-point scale the degree of difficulty in performing the following procedures: lesion marking, mucosal pre-cutting, circumferential incision, submucosal dissection, and hemostasis. After the simulator training, the participants completed a questionnaire regarding their opinions on the degree of realism and the feasibility of using this model for training. After watching an instructional video, attendees felt that the most difficult techniques were submucosal dissection and hemostasis. After using the artificial tissue simulator model, the attendees felt more confident in performing performing lesion marking (p = 0.026) and submucosal dissection (p = 0.037). However, they still felt that hemostasis was the most difficult techniques to master. Overall, the attendees thought the simulator was realistic in simulated lesion marking and its use was feasible for simulated lesion marking and submucosal dissection. Our pilot study shows the feasibility of using a novel artificial tissue in performing ESD and we believe that the artificial tissue simulator acts well as a bridge between instructional videos and animal model training. The model is reusable and inexpensive, and could disseminate the techniques of the ESD more easily and quickly.

31 July 2024 in Intestinal Research
Verified
Journal Article
Open access
PDF file
JWJia-Feng Wu
Jia-Feng Wu
HYHsu-Heng Yen
Hsu-Heng Yen
HWHorng-Yuan Wang
Horng-Yuan Wang
TCTing-An Chang
Ting-An Chang
CCChung-Hsin Chang
Chung-Hsin Chang
PTPO-NIEN TSAO
PO-NIEN TSAO
Crohn’s disease (CD) is a chronic, fluctuating inflammatory condition that primarily affects the gastrointestinal tract. Although the incidence of CD in Taiwan is lower than that in Western countries, the severity of CD presentation appears to be similar between Asia and the West. This observation indicates the urgency for devising revised guidelines tailored to the unique reimbursement system, and patient requirements in Taiwan. The core objectives of these updated guidelines include the updated treatment choices and the integration of the treat-to-target strategy into CD management, promoting the achievement of deep remission to mitigate complications and enhance the overall quality of life. Given the diversity in disease prevalence, severity, insurance policies, and access to medical treatments in Taiwan, a customized approach is imperative for formulating these guidelines. Such tailored strategies ensure that international standards are not only adapted but also optimized to local contexts. Since the inception of its initial guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease (TSIBD) has acknowledged the importance of continuous revisions for incorporating new therapeutic options and evolving disease management practices. The latest update leverages international standards and recent research findings focused on practical implementation within the Taiwanese healthcare system.

15 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JLJian-Han Lai
Jian-Han Lai
KLKeng-Han Lee
Keng-Han Lee
CCChen-Wang Chang
Chen-Wang Chang
MCMing-Jen Chen
Ming-Jen Chen
CLChing-Chung Lin
Ching-Chung Lin
Diagnosing pancreatic malignancy is challenging, especially in patients with chronic pancreatitis (CP). Endoscopic ultrasonography (EUS) is a promising diagnostic procedure for discriminating between malignancy and CP. We aimed to investigate the predictive factors and reliability of computed tomography (CT) and EUS for differentiating pancreatic mass lesions and the diagnostic accuracy of EUS-FNA or FNB in patients with CP. Forty patients with CP, receiving CT and EUS-FNA or FNB for pancreatic mass lesion evaluation, were enrolled in the study. Patients’ data, CT and EUS characteristics, image-based diagnosis, cytopathology, and final diagnosis were recorded. EUS was superior to CT in terms of diagnostic accuracy (92.5% vs. 82.5%, p = 0.02). Both CT and EUS showed significant predictive factors (all p < 0.05) with the tumor image hypoattenuation pattern or vessel invasion on CT and pancreatic duct dilatation, or distal pancreatic atrophy on EUS. EUS imaging is a reliable modality for evaluating pancreatic lesions, even with a CP background. The EUS image has a higher diagnostic accuracy than CT. Predicting factors, including hypoechoic pattern, pancreatic duct dilatation, and distal pancreas atrophy, may help to differentiate benign or malignant in patients with CP.

31 January 2026 in Intestinal Research
Verified
Journal Article
Open access
PDF file
WLWei-Chen Lin
Wei-Chen Lin
CLChunChi Lin
ChunChi Lin
WHWen-Hung Hsu
Wen-Hung Hsu
FCFENG FAN CHIANG
FENG FAN CHIANG
CCChen-Wang Chang
Chen-Wang Chang
PTPO-NIEN TSAO
PO-NIEN TSAO
Background/Aims: Data from Asia regarding the short-term and long-term outcomes for acute severe ulcerative colitis (ASUC) are limited. We assessed the outcomes of ASUC, identified the risk factors for colectomy, and compared colectomy rates between the pre-biologics and post-biologics eras in Taiwan. Methods: The patients with an ASUC diagnosis between January 2013 and March 2022 at 5 tertiary medical centers were retrospectively analyzed. Results: In total, 98 patients were enrolled, with 68.4% diagnosed in the post-biologics era. In 78.6% of the ASUC patients initially received intravenous steroid therapy, for which the success rate was 74.1%. As for rescue therapy, 15 patients (93.8%) received biologics and 1 (6.3%) received cyclosporin. Biologics rescue therapy had a 93.3% success rate. One (1%) mortality due to septic shock occurred. The colectomy rate for index ASUC admission was 11.2%. Patients receiving colectomy were predominantly male (P= 0.012) and at older age (P= 0.016). Higher C-reactive protein (P= 0.035), lower albumin (P= 0.017), and hemoglobin (P= 0.023) levels were associated with colectomy risk. During a median follow-up of 24 months, 13 patients (15.1%) had recurrent ASUC and 23.1% of patients received colectomy. The accumulated colectomy rate at 3 years did not differ between the pre- and post-biologics eras (16.1% vs. 13.4%, P= 0.270). Conclusions: This is the first Asian study on ASUC to compare colectomy rates between the prebiologics and post-biologics eras, revealing no significant difference. The recurrent ASUC had a higher colectomy rate than the index ASUC.

1 August 2010 in The American Journal of Surgery
Verified
Journal Article
Closed access
YHYuan-Chun Hsu
Yuan-Chun Hsu
CCChen-Wang Chang
Chen-Wang Chang
CLChun-Lu Lin
Chun-Lu Lin
CLChuan-Tsai Lai
Chuan-Tsai Lai